Surgicel — Oxidized Regenerated Cellulose
Surgicel (oxidized regenerated cellulose, ORC) is a plant-cellulose-derived hemostatic matrix — a sterile, absorbable, knitted fabric that controls capillary and small-venous bleeding by contact activation of platelets and mechanical tamponade. It is one of the oldest and most widely used passive hemostatic agents in surgery (introduced 1945, Johnson & Johnson).[1]
Mechanism
- Cellulose fibers are chemically oxidized to introduce carboxylic acid groups — producing a low-pH, locally acidic microenvironment when hydrated
- The acidic pH denatures plasma proteins and activates platelet aggregation on the matrix surface
- Forms a gel-like coagulum as it absorbs blood
- Mechanical tamponade provides secondary hemostatic effect
- Fully absorbed within 7–14 days via phagocytosis and hydrolysis
Surgicel is a passive matrix — it enhances local clot formation but does not contain thrombin or other active coagulation factors. Efficacy depends on the patient's native clotting capacity.
Product Forms
| Form | Texture | Best for |
|---|---|---|
| Surgicel Original | Knitted fabric (pad) | Sheet placement on bleeding surface |
| Surgicel Fibrillar | Fluffy cotton-like | Packing into crevices / irregular cavities |
| Surgicel SNoW | Structured nonwoven | Higher tensile strength; broader sheets |
| Surgicel Powder | Fine powder | Broad diffuse oozing |
GU Applications
- Partial nephrectomy renal bed — placement after sliding-clip renorrhaphy for diffuse capillary oozing; avoid contact with the collecting system (stone nidus risk)
- Pelvic sidewall — after lymphadenectomy for residual oozing
- Bladder-neck dissection — controlling diffuse oozing after radical prostatectomy or bladder-neck reconstruction
- Urethroplasty donor bed — control of bed bleeding at graft harvest sites (buccal mucosa, penile skin)
- Retropubic space — after closure of large pelvic dissections
- Neurovascular-bundle protection during RARP — thin strip placed over the NVB for hemostasis without cautery-related thermal injury
- Scrotal / perineal wounds — Fournier's debridement residual oozing
Technique Pearls
- Pre-cut the sheet to the size of the bleeding area — oversize increases residual foreign-body volume
- Apply with dry gloved hands — moist contact prematurely activates the gel-forming properties
- Hold in place 3–5 minutes with a dry sponge; do not wipe or rinse
- Remove excess before closure — large volumes produce bulky foreign-body mass on imaging and can serve as a stone nidus in urinary-tract contact
- Never use intravascularly — can cause embolic events
- Does not work in rapid arterial bleeding — control the arterial source first with suture or clip
Limitations and Cautions
- Stone nidus in urinary tract — avoid direct contact with urinary mucosa or within the collecting system
- Foreign-body granuloma — retained Surgicel can mimic tumor on follow-up imaging months to years later; document placement in operative note
- Low efficacy in heparinized / coagulopathic patients — passive matrices depend on native clotting; use an active (thrombin-containing) agent instead
- Can compress adjacent nerves as it swells
- Not ideal for high-flow bleeding — control the source first
Surgicel vs. Alternatives
| Agent | Mechanism | Best for vs. Surgicel |
|---|---|---|
| Surgicel | Passive matrix + acid-pH platelet activation | Broad / sheet-like raw surfaces; no coagulopathy |
| Gelfoam | Passive matrix, neutral pH | Bone bleeding; can combine with thrombin |
| Arista AH | Passive, absorbs water → concentrates clotting factors | Diffuse oozing; no persistent foreign body after 48 hours |
| FloSeal | Active — contains thrombin | Coagulopathic patient; high-volume oozing |
| Topical thrombin | Active — pure thrombin | Combined with Gelfoam for targeted activity |
See Also
References
1. Seyednejad H, Imani M, Jamieson T, Seifalian AM. Topical haemostatic agents. Br J Surg. 2008;95(10):1197–225. doi:10.1002/bjs.6357